Tag: Food and Drug Administration
Putting Right-to-Try Drug Prices in Perspective
Raymond J. March  •  Monday, July 2, 2018
EpiPen Pricing Controversy Reveals Ignorance about Market Competition
Raymond J. March  •  Friday, June 22, 2018
Dear Congress, Please Don’t Keep Up with the Kardashians!
Raymond J. March  •  Thursday, June 21, 2018
FDA Moves Closer to Approving Ecstasy
Raymond J. March  •  Tuesday, June 19, 2018
Right-to-Try Law Signed!
Raymond J. March  •  Monday, June 18, 2018
Curing Diseases Is Sustainable, Government in Healthcare Is Not
Raymond J. March  •  Thursday, May 3, 2018
FDA Cracks Down on Online Eye-Exam Company
Raymond J. March  •  Thursday, April 5, 2018
The FDA Plans to Regulate Nicotine in Cigarettes
Raymond J. March  •  Tuesday, April 3, 2018
American Patients Can Access Far More New Cancer Drugs than Others Can
John R. Graham  •  Monday, February 13, 2017
Congress Just Punched a Big Hole in Obamacare
John R. Graham  •  Wednesday, December 21, 2016
The FDA Cannot Hire Staff with Starting Salaries of $160,000
John R. Graham  •  Friday, November 4, 2016
Good and Bad News on Generic Drug Approvals
John R. Graham  •  Tuesday, October 18, 2016
Who Benefits from “Right to Try” Laws?
John R. Graham  •  Tuesday, October 4, 2016
One Solution to the EpiPen Crisis: Repeal Durham-Humphrey!
John R. Graham  •  Tuesday, September 27, 2016
EpiPen: A Case Study of Government Harm
John R. Graham  •  Tuesday, August 30, 2016
FDA Driving Drug Prices into Stratosphere
John R. Graham  •  Wednesday, October 7, 2015
Game Developers Face Final Boss: The FDA
Aaron Tao  •  Thursday, August 20, 2015
Victory for Free Speech in Medicine
John R. Graham  •  Tuesday, August 18, 2015
Can the Rampaging Leviathan Be Stopped or Slowed?
Robert Higgs  •  Monday, November 2, 2009
« Newer Posts
  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621-1428 | (510) 632-1366 | (510) 568-6040 FAX | SEND EMAIL